Skip to content

High-field Brain Magnetic Resonance Spectroscopy

Technical Developments for High-field Brain Magnetic Resonance Spectroscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02053701
Enrollment
30
Registered
2014-02-04
Start date
2010-06-01
Completion date
2030-11-01
Last updated
2026-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

magnetic resonance spectroscopy, quantification precision, brain, brain metabolites

Brief summary

Magnetic resonance spectroscopy (MRS) allows non-invasive measurement of the concentration of up to 18 metabolites in the brain ("neurochemical profile"). The objective of this proposal is to develop new methods for high-field brain MRS (3 to 7 Tesla). Our main hypothesis is that higher magnetic fields lead to improved spatial and temporal resolution and improved quantification precision. Aims 1. To obtain improved "neurochemical profiles" in the brain using single voxel proton MRS at very high field (3 Tesla to 7 Tesla). 2. To develop new methods for proton magnetic resonance spectroscopic imaging (MRSI) to obtain metabolic maps at very high field (3 Tesla to 7 Tesla). Since this project is focused on technical development, only healthy volunteers will be recruited (no patients).

Interventions

None listed

Sponsors

University of Minnesota
Lead SponsorOTHER
National Institute for Biomedical Imaging and Bioengineering (NIBIB)
CollaboratorNIH

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* over 18 years old

Exclusion criteria

* no metallic implant or other MRI-incompatible device

Design outcomes

Primary

MeasureTime frameDescription
Precision of quantification of brain metabolites concentrationsOne time onlyThis protocol is devoted exclusively to technical development and testing of MRS methods on our MR scanners. As such, there is no well-defined outcome measure or time frame. It is a continuous effort. We recruit subjects on an ongoing basis to test, optimize, and assess the performance of newly developed techniques.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORPierre-Gilles Henry, PhD

Center for Magnetic Resonance Research, University of Minnesota

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 20, 2026